comparemela.com

Latest Breaking News On - Research for prevention conference - Page 10 : comparemela.com

African nations lead the world in offering PrEP HIV prevention drug

Daniel Born/The Times/Gallo Images/Getty Images Nearly 1 million people are now taking pre-exposure prophylaxis (PrEP), medicine that can slash the risk of HIV infections. While early use of the drug was mostly limited to Western nations, the number of users in sub-Saharan Africa (SSA) has now drastically increased, accounting for more than half of the world’s PrEP users. Kate Segal at AVAC, a New York-based non-profit focused on global HIV prevention, presented the latest data on PrEP use at the virtual HIV Research for Prevention Conference on 26 January. She said there had been a major expansion of PrEP users in 2020, with a rise of more than 300,000 from the previous year. In SSA, expanded access saw the number of new users jump from 4154 in 2016 to more than 517,000 in 2020, representing 56 per cent of the global total.

New ethical obligations for researchers in places where existing HIV prevention services are inadequate

Peter Godfrey-Faussett (top right) presenting at HIVR4P 2021. A full package of effective prevention interventions, up to international standards, must be offered to people taking part in HIV prevention trials, say UNAIDS and WHO in new guidance issued this week. This means that if researchers want to run a study in a country in which PrEP is not routinely available, they must find a way to provide it to study participants. If the study demonstrates that a new product is effective, the researchers have new obligations to provide it to study participants at the end of the trial and help make it available to the wider population.

HIV testing, condom use: Nigeria, other African countries may not meet 2030 targets | International Centre for Investigative Reporting

By Tobore Ovuorie ANALYSIS of data from 38 African countries indicates very few, if any, are on track to reach the UNAIDS targets for HIV testing and condom use by the year 2030. This was one of the major highlights in HIV prevention research announced Tuesday at the 4 th HIV Research for Prevention Conference (HIVR4P), convened by the International AIDS Society (IAS). The annual gathering of researchers, thinktanks, amongst others in the HIV field holds virtually this year, due to the COVID-19 epidemic. Based on 114 nationally-representative datasets representing more than 1.4 million sexually active people, the study presented by Phuong Nguyen of St. Luke’s International University revealed that overall, the probabilities of reaching the 2030 targets were very low for both HIV testing at 0 percent to 28.5 percent and condom use with 0 percent to 12.1 percent.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.